STEMCELL Technologies’ Post

We’re 🤯 by the latest clinical trial research from Oncologie | UNIL-CHUV! Read our blog to see how they used #singlecell technologies to characterize the tumor-immune features that could be the key to successful adoptive cell therapy in metastatic #melanoma.

In this resource from Cytiva we learn about the potential of tumor-infiltrating lymphocyte therapies for personalized cancer care. Download now to discover insights and proven strategies from researchers for scaling a TIL manufacturing process >>> https://hubs.ly/Q02pMpSC0

We don’t want your blood (samples). We just want you to be able to analyze them with #scRNA-seq—without stressing about your schedule. That’s why we developed a first-of-its-kind protocol to fix whole blood for downstream single cell profiling. Check out our poster from #AACR24 to see what we learned about multiple myeloma by analyzing fixed blood from patients treated with #CART cell therapy: https://bit.ly/4aiko6H

Discover how to engineer and analyze CAR-T cell signaling and activation using cutting-edge tools in our upcoming webinar. Learn from experts about innovative non-viral editing and analytical platforms that enhance CAR-T cell therapy efficiency. #CARTTherapy #GeneEditing #CancerResearch https://lnkd.in/gaQq5EVi

🔍 Join our upcoming webinar to explore the latest advancements in CAR-T cell signaling and activation. Gain insights from leading experts on innovative non-viral editing 🧬 and analytical platforms that are revolutionizing the efficiency of CAR-T cell therapy. 🌟

Carcinomas account for ~90% of cancers. This is why the recent FDA approval of TIL therapy is changing the field of cell therapy. In this podcast, Jason Bock talks with Daniel Levine about this achievement and what is on the horizon with the brilliant next generation TILs in development and in the clinic. #biotech #celltherapy #TILtherapy #endcancer https://lnkd.in/et-A5hUe

⏰ Save The Date - 27th June ⏰ Join our upcoming webinar featuring a panel discussion on methods of streamlining the CAR-T workflow. As CAR-T cell therapy continues to advance it's important to address the challenges that come with it. One key issue is the manufacturing process, which can be costly and time-consuming. That's why efforts to create a more efficient CAR-T cell therapy manufacturing process are crucial. Join this webinar to learn more about the analytical tools that are contributing to these advancements! #celltherapy #CART

Interested in learning more about Orca Bio’s investigational high-precision cell therapies? We partnered with The EBMT on a video that highlights the significant unmet need that exists for patients with #bloodcancer today, Orca Bio’s unique approach, and the potential for our investigational products to change the treatment paradigm. You can check out the video here: https://bit.ly/3Jku5GE #EBMT24 #bloodcancer #AML #oncology #leukemia

How can manufacturers develop workflows to deliver highly individualized cell therapy products while developing processes that can deliver scalable treatments? Master tumor infiltrating lymphocyte therapy manufacturing with this recourse from Cytiva. Download now >>> https://hubs.ly/Q02pMpdk0

This collection of articles from Cytiva explores tumor-infiltrating lymphocytes as cell therapies, delving into the processes for sample collection and processing and guidance for developing a scalable and automated manufacturing workflow. Download now >>> https://hubs.ly/Q02pMp9B0